Yes, you need separate Swissdamed registration even if you already have EUDAMED registration. These are completely independent databases with no connection between them. Switzerland requires its own registration under the Medical Devices Ordinance (MedDO) following the breakdown of the EU–Switzerland Mutual Recognition Agreement. Data must be uploaded to each system separately to maintain compliance in both markets.
What Exactly Is Swissdamed and How Does It Differ From EUDAMED?
Swissdamed is Switzerland’s national medical device database, while EUDAMED serves the entire European Union. Both databases track medical devices and organizations in their respective markets, but they operate as completely separate systems with distinct regulatory frameworks.
The key differences between these systems include:
- Regulatory scope: EUDAMED operates under the European Medical Devices Regulation (MDR 2017/745) and In Vitro Diagnostic Medical Devices Regulation (IVDR 2017/746), serving all EU member states through a unified system, while Swissdamed operates exclusively under Swiss regulations, including the Medical Devices Ordinance (MedDO) and In Vitro Diagnostic Medical Devices Ordinance (IvDO)
- Data elements: Swiss-specific data elements include Swiss market status, Swiss single registration numbers (CHRN), and Swiss authorized representative information, whereas some EU-specific elements, such as market status in EU member states, do not appear in Swissdamed
- Approval processes: Both systems require actor registration before device registration, but approval processes and timelines differ between Swiss authorities and EU competent authorities
While Swissdamed’s data model largely aligns with EUDAMED’s structure, these fundamental differences mean that manufacturers must treat each system as a distinct regulatory requirement with its own compliance obligations and operational procedures.
Do You Need Separate Swissdamed Registration If You Already Have EUDAMED?
Yes. Separate Swissdamed registration is mandatory regardless of existing EUDAMED registration. The two databases have no technical connection, and data cannot be transferred between them. Each system requires independent registration and ongoing maintenance.
This requirement stems from Switzerland’s regulatory independence following the breakdown of the EU–Switzerland Mutual Recognition Agreement. Swiss manufacturers must register directly in Swissdamed, while non-Swiss manufacturers need a Swiss authorized representative (CH-REP) to handle their registration. The CH-REP registers in Swissdamed and links the foreign manufacturer within the system.
The registration process follows similar phases in both systems. Actor registration must be completed first, requiring review and approval by Swissmedic (for Swissdamed) or the relevant EU competent authorities (for EUDAMED). Once actor registration is approved, device registration can proceed. However, the timelines differ significantly. Swissdamed’s actor module became mandatory on August 6, 2024, while device registration becomes mandatory on July 1, 2026, with a transition period ending on December 31, 2026.
What Are the Key Compliance Differences Between Swiss and EU Medical Device Regulations?
The primary compliance differences between Swissdamed and EUDAMED center on several critical areas:
- Registration deadlines: Swissdamed requires actor registration since August 2024 and device registration from July 1, 2026, while EUDAMED mandates actor registration beginning May 28, 2026, with device registration required for all products first placed on the EU market after that date
- Fee structures: Swissdamed charges $330 per device notification starting in July 2026, while EUDAMED operates under different fee arrangements that vary by member state and device type
- Submission methods: Swissdamed currently supports XML uploads only through its interface, while EUDAMED offers multiple submission methods, including manual entry and machine-to-machine connections
- Incident reporting requirements: Swiss regulations require immediate registration for devices subject to serious incidents, field safety corrective actions (FSCAs), or trend reporting starting on July 1, 2026, with specific Swiss-focused vigilance procedures
These differences create distinct compliance pathways that require separate planning and resource allocation. Manufacturers must understand that while both systems share similar data structures, their operational requirements, deadlines, and submission processes demand independent compliance strategies tailored to each regulatory environment.
How Do You Navigate Both Swissdamed and EUDAMED Requirements Efficiently?
Efficient dual compliance requires a strategic approach that leverages similarities while managing distinct requirements:
- Centralized data management: Maintain a single source of device master data aligned with both EUDAMED and Swissdamed data models, reducing duplicate data handling and improving consistency across submissions
- Early testing and validation: Use sandbox environments in both systems to validate technical compatibility and internal workflows, identifying schema misalignments, coding issues, and data-mapping gaps before submission deadlines
- Robust data governance: Establish clear procedures for cleaning and validating device master data, ensuring all records linked to a single Basic UDI are coherent, and mapping each UDI-DI correctly to relevant product families and packaging configurations
- Coordinated stakeholder management: Work closely with authorized representatives and competent authorities to avoid bottlenecks, especially as registration deadlines approach and review volumes increase
- Systematic ongoing monitoring: Maintain current registrations, register new UDIs when relevant device changes occur, and stay informed about interface updates and changing data requirements in both systems
This integrated approach recognizes that neither EUDAMED nor Swissdamed registration is a one-time process, but rather ongoing compliance obligations that require continuous attention and expert management. By treating both systems as interconnected components of a broader European regulatory strategy, manufacturers can achieve compliance efficiency while reducing operational complexity and ensuring full regulatory adherence across both markets.
How MedEnvoy Global Helps With Dual EUDAMED and Swissdamed Compliance
MedEnvoy Global provides comprehensive solutions for manufacturers navigating both EUDAMED and Swissdamed requirements simultaneously. Our integrated approach streamlines dual compliance while ensuring full regulatory adherence across European and Swiss markets through:
- Unified data management platform: Centralized system that aligns device master data with both regulatory frameworks, eliminating duplicate data entry and ensuring consistency across submissions
- Expert regulatory guidance: Specialized knowledge of Swiss and EU requirements, including deadline management, fee structures, and submission protocols for both systems
- Technical integration support: XML file preparation, sandbox testing, and validation services that identify potential issues before official submissions
- Ongoing compliance monitoring: Continuous tracking of regulatory changes, deadline updates, and maintenance requirements for both databases
- Authorized representative coordination: Management of CH-REP relationships and EU-REP requirements to ensure seamless registration processes
Ready to simplify your dual EUDAMED and Swissdamed compliance strategy? Contact MedEnvoy Global today to discover how our integrated solutions can reduce complexity while ensuring complete regulatory adherence across both markets.
Related Articles
- Do I Need German Language Documents to Sell Medical Devices?
- How Do Reimbursement Landscapes Impact Market Entry Sequencing?
- Should You Enter Emerging Markets Early or Late in Your Expansion Strategy?
- What Are the Hidden Costs of Selling in Europe?
- Do I Need Spanish Translation for Medical Device Documents?